-
'Better to go to prison': Israeli ultra-Orthodox rally against army service
-
Bublik downs fourth seed Fritz to reach Paris Masters quarters
-
UN climate fund posts record year as chief defends loans
-
Man Utd must ignore outside noise to go in 'right direction', says Wilcox
-
G7 to launch 'alliance' countering China's critical mineral dominance
-
Wallaby boss Schmidt wary of Ford's 'triple threat'
-
Swedish hate-crime trial shines light on far-right 'fitness clubs'
-
Trump call for nuclear tests sows confusion
-
Chinese EV giant BYD says Q3 profit down 33%
-
ECB holds rates steady with eurozone more resilient
-
Independent Macau media outlet says it will close by December
-
Shares in Jeep-maker Stellantis slump despite rising sales
-
Shelton beats Rublev to reach Paris Masters last eight
-
Trump stirs tensions with surprise order to test nuclear weapons
-
S.Africa court rules ANC leader Luthuli was killed in apartheid 'assault'
-
Stocks slide as investors digest Trump-Xi talks, earnings
-
No GDP data released as US shutdown bites
-
PSG's injured Doue to miss Bayern match, out for several weeks
-
Litchfield ton guides Australia to 338 in World Cup semis
-
S.Africa court rules ANC leader Luthuli killed in apartheid 'assault'
-
With inflation under control, ECB holds rates steady again
-
Nigerian designer embraces 'clashes' and 'chaos' at Lagos Fashion Week
-
Nissan says expects $1.8 bn operational loss in 2025-26
-
Italy court stalls Sicily bridge, triggers PM fury
-
Marseille midfielder Nadir stable after on-pitch collapse
-
Saudis turned down Messi stint ahead of 2026 World Cup, says official
-
Novo Nordisk launches bidding war with Pfizer for obesity drugmaker Metsera
-
Universal says struck first licensing deal for AI music
-
France arrests five new suspects over Louvre heist: prosecutor
-
Record Vietnam floods kill 10, turn streets into canals
-
Trump orders US to start nuclear weapons testing
-
'Significant' Xi, Trump talks win cautious optimism in China
-
French justice minister visits jailed former president Sarkozy
-
Eurozone growth beats expectations in third quarter
-
Bali trial begins for 3 accused of Australian's murder
-
Dutch election a photo finish between far-right, centrists
-
IOC removes Saudi Arabia as host of inaugural Esports Olympics
-
Russia batters Ukraine energy sites, killing two
-
Shell's net profit jumps despite lower oil prices
-
Pakistani security source says Afghanistan talks 'likely' to resume
-
Fentanyl, beans and Ukraine: takeaways from Trump-Xi's 'great meeting'
-
Branson's Virgin moves closer to launching Eurostar rival
-
Russia hits Ukraine energy sites, killing one, wounding children
-
Asia markets fluctuate as investors mull Trump-Xi talks
-
Trump, Xi ease fight on tariffs, rare earths
-
Volkswagen posts 1-billion-euro loss on tariffs, Porsche woes
-
'Fight fire with fire': California mulls skewing electoral map
-
Fentanyl, beans and Ukraine: Trump hails 'success' in talks with Xi
-
'Nowhere to sleep': Melissa upends life for Jamaicans
-
Irish octogenarian enjoys new lease on life making harps
| RBGPF | 0% | 79 | $ | |
| RYCEF | 0.32% | 15.45 | $ | |
| CMSC | -0.48% | 24.125 | $ | |
| RIO | -0.7% | 72.076 | $ | |
| AZN | 0.29% | 82.47 | $ | |
| VOD | 0.38% | 11.945 | $ | |
| BTI | -0.73% | 51.345 | $ | |
| RELX | -0.56% | 44.44 | $ | |
| NGG | 0.53% | 75.95 | $ | |
| GSK | 2.17% | 46.95 | $ | |
| BCC | -0.14% | 70.23 | $ | |
| SCS | 0.72% | 16.075 | $ | |
| CMSD | -0.12% | 24.53 | $ | |
| BCE | -0.75% | 23.315 | $ | |
| JRI | 0.25% | 13.865 | $ | |
| BP | 0.07% | 35.225 | $ |
Fourth jab 'partially' effective against Omicron: Israeli study
Fourth doses of the Pfizer and Moderna vaccines against Covid-19 are only "partially" effective for the Omicron variant of the virus, the authors of an Israeli trial said Monday.
A team from Sheba Medical Center near Tel Aviv began conducting a trial in December on fourth doses of coronavirus vaccines, inoculating 154 hospital personnel with Pfizer jabs and 120 other volunteers with Moderna doses.
Preliminary results of the trial "have shown that the vaccines are safe and have shown to produce substantial antibodies, but are only partially effective in defending against the Omicron variant," the hospital said in a statement.
Professor Gili Regev-Yochay, who leads the study, said that while there was an increase in antibodies after administering a fourth dose, it nonetheless "only offers a partial defenser against the virus" for those infected with the Omicron variant.
The vaccines were "extremely effective against the earlier variants," Regev-Yochay noted.
Israel was among the first countries to launch mass immunisation campaigns for its population.
It then began offering booster shots last summer, and has since greenlighted fourth shots for elderly and vulnerable populations.
More than 537,000 Israelis have received a fourth dose of vaccine, according to the health ministry's latest figures.
More than 80 percent of Israel's adult residents have received two coronavirus vaccine shots and more than half have also been given a booster.
- Reduced quarantine -
Meanwhile, the Israeli government on Monday said it was reducing the quarantine period for positive cases from seven to five days, as a record number of infections threatens to overburden the economy.
"This decision will enable us to continue safeguarding public health on the one hand and to keep the economy going at this time on the other, even though it is difficult," Prime Minister Naftali Bennett said in a short video message sent by his office.
Faced with skyrocketing infections fuelled by the Omicron variant, Israel has become the latest country to reduce quarantine periods, after similar moves from France, Spain, Argentina, the United States and Britain.
Israel shuttered its borders after discovering one case infected with the Omicron variant in November, but reopened in early January, despite a spike in infections.
In total, more than 1.7 million infections have been recorded since the start of the pandemic in Israel, including more than 8,300 deaths, according to official figures.
L.Dubois--BTB